US Patent 11744879 Recombinant FSH composition for controlled ovarian stimulation

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11744879

Patent Inventor Names

Lisbeth Helmgaard

Bjarke Mirner Klein

Joan-Carles Arce Saez

Date of Patent

September 5, 2023

Patent Application Number

16642777

Date Filed

August 31, 2018

Patent Citations

‌

US Patent 8951967 Recombinant FSH including alpha 2,3- and alpha 2,6-sailylation

‌

US Patent 9320778 Method for controlled ovarian stimulation with combined FSH and hCG

‌

US Patent 9546204 Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation

‌

US Patent 9694052 FSH composition and methods for controlled ovarian stimulation

‌

US Patent 9771407 Pharmaceutical preparation

‌

US Patent 10064920 Method for controlled ovarian stimulation using FSH and hCG

‌

US Patent 10413592 Methods of treating infertility

‌

US Patent 10464984 Optimized nucleic acid sequences coding for the alpha-chain of human chorionic gonadotropin

...

Patent Primary Examiner

‌

Christina M Borgeest

Preparations including FSH, for example recombinant FSH, for use in the treatment of infertility in patients having high AMH and low bodyweight.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11744879 Recombinant FSH composition for controlled ovarian stimulation

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11744879 Recombinant FSH composition for controlled ovarian stimulation